SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-035774
Filing Date
2020-02-13
Accepted
2020-02-13 17:12:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d861704dsc13g.htm SC 13G 46438
  Complete submission text file 0001193125-20-035774.txt   47731
Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310
Prevail Therapeutics Inc. (Subject) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91049 | Film No.: 20611979
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address
Abeliovich Asa (Filed by) CIK: 0001778476 (see all company filings)

Type: SC 13G